Who gains from more information on the quality of pharmaceutical drugs? Are there incentives for voluntary post-approval clinical trials among pharmaceutical companies? Contrary to popular belief, this paper shows that it is not in the consumer interest that clinical evidence establishing the...

The world’s leading pharmaceutical laboratories are racing to complete trials and begin marketing an effective SARS-CoV-2 vaccine. International Health Organizations and National Public Health Agencies are charged with setting standards for successful completion of Phase 3 trials. Brand...